The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience.
Andres F EspinozaAshley E MontgomeryNicholas C MaamariHeather A DickersonAndras HeczeySanjeev A VasudevanJennifer H FosterPublished in: Pediatric blood & cancer (2024)
Patients with HB and CHD have similar survival compared to those without CHD. Our data support that patients with HB and CHD should be treated with curative intent including cardiac surgical intervention, medical oncology therapy, and oncological surgery for their HB.
Keyphrases
- congenital heart disease
- rectal cancer
- minimally invasive
- randomized controlled trial
- healthcare
- free survival
- palliative care
- coronary artery bypass
- left ventricular
- electronic health record
- big data
- prostate cancer
- stem cells
- surgical site infection
- robot assisted
- bone marrow
- acute coronary syndrome
- percutaneous coronary intervention
- prognostic factors
- mesenchymal stem cells
- coronary artery disease
- replacement therapy
- atrial fibrillation
- chemotherapy induced